Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.52 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067841 | 1.00 | GNPAT (0.62) | GNPATNOD1FOLH1NAALAD2RIMKLA | |
| SCHEMBL20380830 | 0.89 | NOD1 (0.61) | GNPATNOD1FOLH1NAALAD2RIMKLA | |
| SCHEMBL28378530 | 0.88 | NOD1 (0.59) | GNPATNOD1FOLH1NAALAD2RIMKLA | |
| SCHEMBL71687 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL18560506 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL23601770 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL14478728 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL18783045 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL14725995 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C | |
| SCHEMBL14685779 | 0.87 | NOD1 (0.69) | GNPATNOD1SLC6A5PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |